- Home
- CSTL vs CRMT Comparison
CSTL vs CRMT Comparison
Compare CSTL & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- CRMT
- Stock Information
- Founded
- CSTL 2007
- CRMT 1981
- Country
- CSTL United States
- CRMT United States
- Employees
- CSTL N/A
- CRMT N/A
- Industry
- CSTL Medical Specialities
- CRMT Other Specialty Stores
- Sector
- CSTL Health Care
- CRMT Consumer Discretionary
- Exchange
- CSTL Nasdaq
- CRMT Nasdaq
- Market Cap
- CSTL 456.2M
- CRMT 389.6M
- IPO Year
- CSTL 2019
- CRMT N/A
- Fundamental
- Price
- CSTL $19.46
- CRMT $60.77
- Analyst Decision
- CSTL Strong Buy
- CRMT Hold
- Analyst Count
- CSTL 6
- CRMT 1
- Target Price
- CSTL $37.67
- CRMT $50.00
- AVG Volume (30 Days)
- CSTL 462.3K
- CRMT 145.4K
- Earning Date
- CSTL 08-04-2025
- CRMT 06-12-2025
- Dividend Yield
- CSTL N/A
- CRMT N/A
- EPS Growth
- CSTL N/A
- CRMT N/A
- EPS
- CSTL N/A
- CRMT 2.33
- Revenue
- CSTL $347,083,000.00
- CRMT $1,390,932,000.00
- Revenue This Year
- CSTL N/A
- CRMT $1.95
- Revenue Next Year
- CSTL $1.36
- CRMT $10.30
- P/E Ratio
- CSTL N/A
- CRMT $25.86
- Revenue Growth
- CSTL 38.43
- CRMT 0.14
- 52 Week Low
- CSTL $15.45
- CRMT $36.40
- 52 Week High
- CSTL $35.84
- CRMT $72.26
- Technical
- Relative Strength Index (RSI)
- CSTL 55.41
- CRMT 66.71
- Support Level
- CSTL $18.18
- CRMT $55.19
- Resistance Level
- CSTL $20.63
- CRMT $62.55
- Average True Range (ATR)
- CSTL 0.77
- CRMT 2.25
- MACD
- CSTL 0.07
- CRMT 0.91
- Stochastic Oscillator
- CSTL 57.36
- CRMT 87.50
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.